Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;83(2):237-279.
doi: 10.1016/j.jinf.2021.05.021. Epub 2021 May 28.

Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination

Affiliations
Comment

Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination

Adeel A Butt et al. J Infect. 2021 Aug.
No abstract available

Keywords: Moderna mRNA-1273; Pfizer BNT-162b2; SARS-CoV-2; Vaccine effectiveness; Vaccines; Veterans.

PubMed Disclaimer

Comment on

References

    1. Sansone E., Tiraboschi M., Sala E. Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy. J Infect. 2021 - PMC - PubMed
    1. Dagan N., Barda N., Kepten E. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412–1423. - PMC - PubMed
    1. Keehner J., Horton L.E., Pfeffer M.A. SARS-CoV-2 infection after vaccination in health care workers in California. N Engl J Med. 2021 doi: 10.1056/NEJMc2101927. - DOI - PMC - PubMed
    1. Daniel W., Nivet M., Warner J., Podolsky D.K. Early evidence of the effect of SARS-CoV-2 vaccine at one medical center. N Engl J Med. 2021 doi: 10.1056/NEJMc2102153. - DOI - PMC - PubMed
    1. Krammer F., Srivastava K., Alshammary H. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med. 2021 doi: 10.1056/NEJMc2101667. - DOI - PMC - PubMed